AI

At the India AI Impact Summit 2026 in New Delhi, an unexpected voice captured national attention: eight-year-old coder Ranvir Sachdeva. Sharing the stage with global technology executives and policymakers, the young technologist spoke about linking ancient Indian philosophical thought with modern artificial intelligence frameworks. His appearance underscored the growing democratization of technology education and the emergence of youth-led innovation in India’s digital ecosystem.

Artificial intelligence (AI) is revolutionizing cancer pathology, enhancing diagnostic accuracy, efficiency, and personalized treatment planning. By leveraging machine learning algorithms, deep learning models, and image recognition technologies, AI can analyze histopathological slides at unprecedented speed, identifying subtle cellular patterns that may elude human pathologists. Integrating AI into pathology workflows reduces diagnostic variability, accelerates turnaround times, and supports precision oncology initiatives.

Amazon CEO Andy Jassy has acknowledged that artificial intelligence will inevitably displace certain roles within the company, while simultaneously creating new categories of employment. His remarks underscore a broader transformation unfolding across global enterprises as automation and generative AI accelerate operational efficiency. Jassy emphasized that technological disruption is not unprecedented but will require proactive reskilling and strategic workforce planning.

India is rapidly positioning itself as a global force in artificial intelligence, with growing collaboration between domestic institutions and global research leaders such as Google DeepMind. The focus is shifting from elite, centralized AI innovation toward democratized access to advanced tools, research, and applications. Policymakers, academia, and industry stakeholders are aligning efforts to ensure AI benefits extend beyond metropolitan technology hubs to startups, public services, and small enterprises.

Eko Health is spearheading innovation in cardiovascular care by integrating artificial intelligence (AI) with medical diagnostics. Their AI-enabled platforms analyze heart sounds, electrocardiograms, and other physiological data to detect early signs of cardiac abnormalities, enhancing accuracy and accelerating intervention. This technological advancement not only improves patient outcomes but also has significant Rs.-denominated implications for reducing healthcare costs, optimizing clinical workflows, and scaling preventive care.

South Korean electronics major Samsung is accelerating its push into artificial intelligence–enabled smartphones in India, signaling a strategic shift toward premium innovation and differentiated user experiences. As competition intensifies in the world’s fastest-growing large smartphone market, Samsung is positioning AI as a core feature rather than a value add. From intelligent cameras to on-device productivity tools, the company is leveraging AI to strengthen its ecosystem and defend market share.

Samsung has expanded its premium computing portfolio with the launch of the Galaxy Book6 series, underscoring a decisive push into AI-enabled personal computing. Powered by Intel Core Ultra processors, the new lineup blends high-performance hardware with on-device artificial intelligence capabilities designed to enhance productivity, security and energy efficiency. The move reflects a broader industry shift toward AI-native PCs as manufacturers seek to redefine user experiences beyond incremental hardware upgrades.

India’s market regulator is stepping up the use of artificial intelligence and advanced technology to enhance surveillance across capital markets, aiming to detect manipulation, insider trading and systemic risks more effectively. The initiative reflects a strategic shift toward data-driven oversight as trading volumes, product complexity and retail participation continue to rise. By leveraging AI-led analytics, the regulator intends to move from reactive enforcement to predictive supervision.

Artificial intelligence is increasingly reshaping how breast cancer is detected, offering radiologists advanced tools to improve diagnostic accuracy and speed. By analyzing medical images with high precision, AI systems can flag subtle patterns that may be missed in routine reviews, supporting earlier detection and more confident clinical decisions. While AI does not replace human expertise, it is becoming a critical assistive technology in breast imaging workflows.

India’s market regulator has raised concerns over the growing misuse of artificial intelligence in financial markets, warning that AI-driven misinformation and exaggerated technology claims could undermine investor trust. The Securities and Exchange Board of India (Sebi) has cautioned intermediaries and listed companies against “AI washing,” where artificial intelligence is overstated or misleadingly marketed to attract investors. As AI adoption accelerates across trading, advisory, and compliance functions, regulators are emphasizing transparency, accountability, and robust governance.